The statistical comparison of clinical trials

Area of Science:

• Pharmacological research
• Clinical trial methodology
• Statistical analysis

Background:

• Meaningful statistical comparison of clinical trials is crucial for evidence-based practice.
• Atypical antipsychotics are widely used, necessitating reliable comparative data.
• Existing clinical trials often lack uniformity, hindering direct comparisons.

Purpose of the Study:

• To evaluate the feasibility of statistically comparing 5 clinical trials on atypical antipsychotics.
• To identify challenges in making meaningful statistical comparisons across studies.
• To assess the reliability of observed differences between atypical antipsychotics based on available trial data.

Main Methods:

• Review of 5 clinical trials comparing atypical antipsychotics.
• Assessment of internal and external validity across trials.
• Analysis of methodological uniformity, including effect size reporting.
• Examination of statistical comparability based on study protocols.

Main Results:

• Significant heterogeneity in trial protocols prevents direct statistical comparisons.
• Areas such as effect size lack uniformity, making cross-trial analysis impossible.
• Judgments on internal and external validity are possible but limited.
• Observed differences between atypical antipsychotics may not exceed random variation.

Conclusions:

• Direct statistical comparison of the 5 atypical antipsychotic trials is not statistically sound.
• Methodological inconsistencies across trials limit the ability to draw definitive conclusions.
• The observed differences between atypical antipsychotics in these trials are likely attributable to chance rather than true pharmacological effects.